BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Adipose tissue
,
DNA fingerprint
,
Tamoxifen
,
rs2230926
,
IGF1
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
undifferentiated carcinoma of nasopharynx
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Nasopharyngeal carcinomas at different clinical stages
Nasopharyngeal carcinoma HONE1 irradiated cells with ebv-miR-BART7 mimic gene overexpression
Expression data from biopsies of Nasopharyngeal carcinoma (NPC) and controls
Explore Curated Studies Results
Literature
Most Relevant Literature
Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated ca…
Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal canc…
Bilateral neck metastases in upper aero-digestive tract cancer: emphasis on the distribution of lymp…
BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
Isolated osteoradionecrosis of the dens mimicking metastasis of nasopharyngeal carcinoma after radio…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
Demethylated Drug in the Treatment of Nasopharyngeal Carcinoma
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Adv…
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiothe…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ